Putnam Associates’ strength lies in solving problems that involve the complex interactions of patients, physicians, payers, healthcare institutions, and regulators. Clients appreciate our ability to rigorously structure strategic problems, and to apply robust quantitative analytics and effective synthesis across scientific, clinical, and business disciplines. We do not define our client’s issues to fit our capabilities. Instead, we listen to client needs, help form hypotheses and shape lines of inquiry, and tailor our comprehensive set of tools, techniques and expertise to appropriately assemble data, analyze and interpret findings to form the basis of our recommendations.
Putnam often supports senior executives in analyzing major strategic opportunities. Recent engagements include:
After a rigorous evaluation, Putnam helped a mid-sized pharma company identify a number of promising growth opportunities within their newly reorganized business units.How We Helped
Putnam brings extensive process experience and deep therapeutic area expertise to portfolio optimization and L&D analyses. Recent engagements include:
Putnam performed extensive epidemiological research for a biotech company that was conducting early-phase clinical trials for a novel small molecule providing the client with the strategic direction they need to drive development goals.How We Helped
Putnam has supported many of the most exciting pipeline agents and new therapies introduced over the last decade, including more than two dozen first-in-class agents – among them six therapies designated as “Breakthrough” by FDA – more than a dozen orphan disease products, and 10+ drugs that have achieved blockbuster status, or are expected to.
Teaming with Putnam, an early stage company expecting imminent approval for a new anti-infective created a value story and product positioning that ensured a successful launch.How We Helped
Putnam applies strategy consulting disciplines and sophisticated quantitative analytics to strategic marketing problems. We are particularly renowned for therapeutic area depth (including clinical and epidemiological literature scans and synthesis as a component of many projects), state of the art analytics – modeling, segmentation, claims data analysis – and primary physician (KOL, Institutional, and Community), patient, and/or payer research. Examples from recent engagements include:
Putnam leveraged their experience to directly impact the success of a small molecule franchise observing a surprisingly wide variety of treatment patterns across physicians in high-level market research.How We Helped
Putnam is a leader in global pricing & reimbursement analysis, supporting many prominent launches over the last decade in Global, EU and US markets, and helping to craft the Loss-of-Exclusivity (LOE) strategies for prominent franchises. Examples include:
With in-depth qualitative consultations and analysis, Putnam developed a strategy which facilitated an increase in pricing and revenue for a growing company’s newly acquired product.How We Helped
Putnam also works with clients on other strategic projects that require rigorous analysis and custom solutions.
Putnam focuses solely on the life science industries, allowing us to provide unparalleled depth, experience and insight into our client’s most complex challenges.
We do not define our client’s issue to fit our capabilities. Instead, we listen to their needs and tailor our comprehensive set of tools, techniques and expertise to quickly bring clarity to complex issues facing our clients.
Understanding the global challenges facing our clients enables us to provide customized, actionable and strategic recommendations that draw on deep therapeutic area and functional expertise.